Aclarion, Inc. cash flow statement

In fiscal 2025, Aclarion, Inc.'s operations generated −$7.2m of cash; it spent $21,528 on capital projects, leaving free cash flow of −$7.2m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aclarion, Inc.: cash flow statement, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash from operations	−2,400	−4,949	−3,647	−5,272	−7,164	−8,087
Depreciation and amortisation	186	144	163	193	227	182
Stock-based pay	177	1,187	456	287	105	128
Capital spending	—	—	0	5	22	—
Free cash flow	—	—	−3,647	−5,277	−7,186	—
Free cash flow after stock pay	—	—	−4,103	−5,564	−7,291	—
Share buybacks	60	—	—	—	—	—
Shares issued	0	8,552	0	0	5,703	1,571

US$ thousands unless shown otherwise. Fiscal quarters.

Aclarion, Inc.: cash flow statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Cash from operations	−1,056	−923	−2,511	−1,866	−1,160	−1,627	−2,642	−2,657
Depreciation and amortisation	50	52	55	0	58	61	61	1
Stock-based pay	75	57	56	28	17	4	5	102
Capital spending	0	5	—	—	7	14	—	0
Free cash flow	−1,056	−928	—	—	−1,168	−1,641	—	−2,657
Free cash flow after stock pay	−1,130	−985	—	—	−1,184	−1,646	—	−2,759
Shares issued	0	0	5,168	0	0	535	1,036	0

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ACON vs ISPC ACON vs YDES ACON vs QSI

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Aclarion, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aclarion, Inc.